Syremis Therapeutics
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
$165M Series A ·
Led by Dexcel Pharma · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 19, 2025 (18 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $165M | fundraisingfox.com |
Timeline
- Website created
Founders and team
EK
Elisabeth Kogan FounderAK
Aaron Koenig Chief Medical Officer
Investors
BBain Capital Life Sciences
DDexcel Pharmalead investor
GGV
PPictet Private Equity Investors S.A.
QQVT Financial
TThird Rock Ventureslead investor
Companies like Syremis Therapeutics
NNormunity$75M Series B+ · Jan 2025
EElkedonia$13M Seed · Jul 2025
CCAD TherapeuticsSeries A · Oct 2026
KKinoxis TherapeuticsSeries B+ · Aug 2024AAmae Health$25M Series B+ · Nov 2025
CConfluence PharmaceuticalsSeries B+ · Jun 2022
Other companies backed by Dexcel Pharma
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/syremis-therapeutics (get a free API key).